GSC
PBE icon

Ground Swell Capital’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Ground Swell Capital’s Portfolio PBE Stock Details PBE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-105
Closed -$5K – 2665
2014
Q2 		$5K Buy
+105
New +$4.25K 0.01% 1093

Other funds holding PBE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
TAM
Trillium Asset Management Boston, Massachusetts $3.01B AUM 19.96% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SAM
SignalPoint Asset Management Springfield, Missouri $411M AUM 23.81% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Ground Swell Capital's PBE Position: Q3 2014 in Review

Ground Swell Capital sold out of Invesco Biotechnology & Genome ETF (PBE) in Q3 2014, closing a stake of 105 shares — an estimated $5K sold.

Ground Swell Capital first reported a position in PBE in Q2 2014 and held it in 1 quarter. The position peaked at $5K in Q2 2014. 70 funds tracked by Wall St. Rank hold PBE as of Q3 2014.

  • Ground Swell Capital reported no remaining Invesco Biotechnology & Genome ETF position as of Q3 2014 after selling out during the quarter.
  • Ground Swell Capital sold 105 Invesco Biotechnology & Genome ETF shares in Q3 2014, an estimated $5K.
  • Ground Swell Capital first reported a position in Invesco Biotechnology & Genome ETF in Q2 2014 and held it in 1 quarter.
  • Ground Swell Capital's Invesco Biotechnology & Genome ETF position peaked at $5K in Q2 2014.
  • 70 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.